CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.5B
AUM Growth
+$378M
(+2.7%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
738
New
61
Increased
261
Reduced
285
Closed
31
Top Buys
| 1 |
Visa
V
|
$77.8M |
| 2 |
Gilead Sciences
GILD
|
$59.3M |
| 3 |
Microsoft
MSFT
|
$46.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$40.2M |
| 5 |
Nu Holdings
NU
|
$39.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$112M |
| 2 |
Royal Bank of Canada
RY
|
$51.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$42.8M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.9M |
| 5 |
Merck
MRK
|
$33.3M |
Sector Composition
| 1 | Technology | 30.32% |
| 2 | Healthcare | 28.88% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.52% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Illinois Tool Works
ITW
$77.6B
| $9.85M | 0.07% |
37,608
+8,929
| +31% | +$2.34M |
|
252
Immunocore
IMCR
$1.87B
| $9.84M | 0.07% |
144,006
-149,005
| -51% | -$10.2M |
|
253
Insmed
INSM
$30.7B
| $9.61M | 0.07% |
310,200
-15,000
| -5% | -$465K |
|
254
Roper Technologies
ROP
$55.8B
| $9.61M | 0.07% |
17,629
+1,453
| +9% | +$792K |
|
255
Church & Dwight Co
CHD
$23.3B
| $9.54M | 0.07% |
100,921
+4,125
| +4% | +$390K |
|
256
Oracle
ORCL
$654B
| $9.49M | 0.07% |
90,051
-1,936
| -2% | -$204K |
|
257
Nurix Therapeutics
NRIX
$758M
| $9.48M | 0.07% |
918,110
-50,000
| -5% | -$516K |
|
258
Essential Utilities
WTRG
$11B
| $9.14M | 0.06% |
244,680
+41,801
| +21% | +$1.56M |
|
259
Guidewire Software
GWRE
$22B
| $9.03M | 0.06% |
+82,818
| New | +$9.03M |
|
260
T-Mobile US
TMUS
$284B
| $8.96M | 0.06% |
55,893
-19,806
| -26% | -$3.18M |
|
|
ALPN
261
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $8.96M | 0.06% |
+470,000
| New | +$8.96M |
|
262
KKR & Co
KKR
$121B
| $8.95M | 0.06% |
108,030
+72,008
| +200% | +$5.97M |
|
263
Moody's
MCO
$89.5B
| $8.9M | 0.06% |
22,797
+3,404
| +18% | +$1.33M |
|
264
Zai Lab
ZLAB
$3.42B
| $8.88M | 0.06% |
+325,013
| New | +$8.88M |
|
265
Booking.com
BKNG
$178B
| $8.85M | 0.06% |
2,495
-1,192
| -32% | -$4.23M |
|
266
Kymera Therapeutics
KYMR
$3.11B
| $8.74M | 0.06% |
343,302
-145,004
| -30% | -$3.69M |
|
267
Citigroup
C
$176B
| $8.74M | 0.06% |
169,902
-371,079
| -69% | -$19.1M |
|
268
UDR
UDR
$13B
| $8.71M | 0.06% |
227,412
-149,525
| -40% | -$5.73M |
|
269
Target
TGT
$42.3B
| $8.61M | 0.06% |
60,487
+26,557
| +78% | +$3.78M |
|
270
Structure Therapeutics
GPCR
$1.27B
| $8.56M | 0.06% |
+210,000
| New | +$8.56M |
|
271
Zurn Elkay Water Solutions
ZWS
$7.71B
| $8.45M | 0.06% |
+287,454
| New | +$8.45M |
|
272
Ares Management
ARES
$38.9B
| $8.44M | 0.06% |
+70,960
| New | +$8.44M |
|
273
Phreesia
PHR
$1.68B
| $8.41M | 0.06% |
363,440
+19,272
| +6% | +$446K |
|
274
ConocoPhillips
COP
$116B
| $8.37M | 0.06% |
72,096
-17,648
| -20% | -$2.05M |
|
275
Ulta Beauty
ULTA
$23.1B
| $8.25M | 0.06% |
16,843
+6,892
| +69% | +$3.38M |
|